FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to a kit for inducing an immune response to Streptococcus pneumoniae. Kit contains: (a) a first immunogenic composition containing a glycoconjugate of S. pneumoniae serotype 15B, 22F, 33F, 12F, 10A, 11A, 8, wherein said glycoconjugates are individually conjugated with CRM197 (cross-reacting material 197); and (b) a second immunogenic composition containing glycoconjugates of S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F, and wherein said glycoconjugates are individually conjugated to CRM197, for concomitant, parallel or sequential administration of the first and second immunogenic compositions, wherein the glycoconjugates represent capsular polysaccharides of said serotypes conjugated with CRM197.
EFFECT: invention can be used for vaccination of human subjects, in particular infants and elderly people, against pneumococcal infections.
12 cl, 16 dwg, 35 tbl, 21 ex
Title | Year | Author | Number |
---|---|---|---|
IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USE THEREOF | 2015 |
|
RU2778704C2 |
IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USE THEREOF | 2015 |
|
RU2687460C2 |
IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCUS VACCINES | 2016 |
|
RU2712622C2 |
IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND APPLICATION THEREOF | 2021 |
|
RU2774075C1 |
IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATED CAPSULE SACCHARIDE ANTIGENS AND THEIR USE | 2015 |
|
RU2771293C2 |
METHODS OF GLYCOGONJUGATION AND COMPOSITION | 2013 |
|
RU2645071C2 |
METHODS OF GLYCOCONJUGATION AND COMPOSITION | 2013 |
|
RU2724840C2 |
IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES | 2018 |
|
RU2762723C2 |
GLYCOCONJUGATION PROCESS | 2013 |
|
RU2672053C2 |
STREPTOCOCCUS PNEUMONIAE CAPSULE POLYSACCHARIDE AND ITS IMMUNOGENIC CONJUGATE | 2019 |
|
RU2803122C2 |
Authors
Dates
2020-05-18—Published
2016-07-18—Filed